Cessation of Acid Suppressing Medications

OTHER2 trials

Sponsors

Dallas VA Medical Center

Conditions

Barrett's EsophagusEsophagitisGastroesophageal Reflux DiseaseReflux Esophagitis

Unknown Phase

The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis

CompletedNCT01733810

Dallas VA Medical CenterEsophagitis, Gastroesophageal Reflux Disease, Reflux Esophagitis

Start: 2013-02-01End: 2019-07-31Updated: 2020-02-05

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

CompletedNCT02579460

Dallas VA Medical CenterBarrett's Esophagus, Gastroesophageal Reflux Disease

Start: 2015-11-30End: 2017-11-30Updated: 2023-09-11

Related Papers

Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett’s oesophagus patients

Gut2024-04-198 citations

Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD

Gut2016-09-3056 citations

Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes

JAMA2016-05-17247 citations